Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector
AbstractThis paper demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade Related Intellectual Property Rights System) in 1995 served to open up new economic opportunities and constraints in the wake of which the winners and losers were selected as a function of the dynamic firm capabilities most appropriate for the new market environment.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT) in its series MERIT Working Papers with number 041.
Date of creation: 2008
Date of revision:
International Marketing; R&D Management; India; Pharmaceutical Sector; Corporate Strategy;
Other versions of this item:
- Suma Athreye & Dinar Kale & Shyama V. Ramani, 2009. "Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector," Industrial and Corporate Change, Oxford University Press, vol. 18(4), pages 729-759, August.
- L11 - Industrial Organization - - Market Structure, Firm Strategy, and Market Performance - - - Production, Pricing, and Market Structure; Size Distribution of Firms
- L22 - Industrial Organization - - Firm Objectives, Organization, and Behavior - - - Firm Organization and Market Structure
- L51 - Industrial Organization - - Regulation and Industrial Policy - - - Economics of Regulation
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology
- M31 - Business Administration and Business Economics; Marketing; Accounting - - Marketing and Advertising - - - Marketing
- O32 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Management of Technological Innovation and R&D
- O34 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Intellectual Property and Intellectual Capital
- O53 - Economic Development, Technological Change, and Growth - - Economywide Country Studies - - - Asia including Middle East
You can help add them by filling out this form.
CitEc Project, subscribe to its RSS feed for this item.
- Dinesh Abrol & Pramod Prajapati & Nidhi Singh, 2011. "Globalization of the Indian Pharmaceutical Industry: Implications for Innovation," Institutions and Economies (formerly known as International Journal of Institutions and Economies), Faculty of Economics and Administration, University of Malaya, vol. 3(2), pages 327-365, July.
- Havas, Attila, 2010. "Diversity in firms’ innovation strategies and activities: Main findings of interviews and implications in the context of the Hungarian national," MPRA Paper 55852, University Library of Munich, Germany.
- Guennif, Samir & Ramani, Shyama, 2010.
"Catching up in pharmaceuticals: a comparative study of India and Brazil,"
MERIT Working Papers
019, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
- Mukherjee, Vivekananda & Ramani, Shyama V., 2008. "R&D cooperation, asymmetric technological capabilities and rationale for technology parks," Dresden Discussion Paper Series in Economics 11/08, Dresden University of Technology, Faculty of Business and Economics, Department of Economics.
- Rakesh Basant, 2010. "Intellectual Property Protection, Regulation and Innovation in Developing Economies: The Case of Indian Pharmaceutical Industry," Working Papers id:3208, eSocialSciences.
- Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.
- Basant, Rakesh, . "Intellectual Property Protection, Regulation and Innovation in Developing Economies - The Case of Indian Pharmaceutical Industry," IIMA Working Papers WP2010-11-02, Indian Institute of Management Ahmedabad, Research and Publication Department.
- Vivekananda Mukherjee & Shyama Ramani, 2011. "R&D cooperation in emerging industries, asymmetric innovative capabilities and rationale for technology parks," Theory and Decision, Springer, vol. 71(3), pages 373-394, September.
- repec:hal:wpaper:hal-00632439 is not listed on IDEAS
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Ad Notten).
If references are entirely missing, you can add them using this form.